FDA Adverse Event Injury Summary report: N

REVI SYSTEM

MDR report key: 22869143 · Received August 21, 2025

Report

Report Number
3012239564-2025-00012
Event Type
Injury
Date Received
August 21, 2025
Date of Event
July 22, 2025
Report Date
August 21, 2025
Manufacturer
BLUEWIND MEDICAL LTD
Product Code
QXM
UDI-DI
07290017912226
PMA / PMN Number
K240037
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
IS
Reporter Occupation
003

Narratives

Additional Manufacturer Narrative · 0

DR. (B)(6) HAS ASSURED THE PATIENT THAT IT IS PART OF THE HEALING PROCESS. PATIENT WILL UPDATE DR. (B)(6) OF ANY CHANGES. PATIENT REPORTS NO MORE PAIN AFTER BEING PRESCRIBED MEDS BY HCP, THE IMPLANT ACTIVATION IS SCHEDULED FOR (B)(6).

Description of Event or Problem · 0

PATIENT CALLED AND REPORTED SHARP BURNING PAIN IN ANKLE NEAR INCISION SITE. SHE SAID THE PAIN STARTED LAST NIGHT, (B)(6) 2025 AROUND 9:30PM AND SHE TOOK HER SLEEPING PILLS THAT HELPED HER GO TO BED. PAIN WOKE HER UP AT 3AM AND SHE HAD TO TAKE OTC PAIN MEDICATION TO GO BACK TO BED. SHE DESCRIBES THE PAIN TO BE AN 8 OUT OF 10 WHEN PRESENT. TODAY THE PAIN HAS BEEN OFF AND ON AND NOT TRIGGERED BY ANY CERTAIN ACTIVITY. SHE DID HAVE AN APPT WITH DR. (B)(6) AND SHE SAID THE INCISION LOOKS GOOD AND NOT SURE WHAT MAY BE CAUSING PAIN. SHE WAS PRESCRIBED GABAPENTIN FOR PAIN WHICH SHE WILL TAKE TODAY. SHE WAS IMPLANTED ON (B)(6) AND YET TO BE ACTIVATED. (B)(6) ADVISED PATIENT TO FOLLOW DR. (B)(6) INSTRUCTIONS OF RESTING, ELEVATING LEG AND TAKING PRESCRIBED MEDICATION OF GABAPENTIN.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
182655 REVI SYSTEM IMPLANTED TIBIAL ELECTRICAL URINARY CONTINENCE DEVICE QXM BLUEWIND MEDICAL LTD KA-9000-0001_US_CM 2401101 07290017912226

Patients

Seq Age Sex Outcome Treatment
1 NA Female Other